Grants Working Group

 

Stem Cell Agency Grants Working Group Meeting

MEETING OF THE
SCIENTIFIC AND MEDICAL RESEARCH FUNDING WORKING GROUP
(GRANTS REVIEW WORKING GROUP)
OF THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)
Organized Pursuant to the
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

DATE:             June 27-29, 2012

LOCATION:   Claremont Hotel
                       41 Tunnel Road
                       Berkeley, CA 94705
                       Ph. 510-843-3000

OPEN SESSION:  June 27th 2:00pm – 2:15pm
1. Call to Order
2. Welcome & Chair’s Comments
3. Public Comment

Members of the public will be invited to provide testimony. Speakers are asked to limit their testimony to three (3) minutes.

CLOSED SESSION:
4. Evaluation of RFA 11-03 Applications June 27th 2:15pm – 6:15pm (est.)
5. Evaluation of RFA 11-03 Applications June 28th 9:00am – 6:00pm (est.)
6. Evaluation of RFA 11-03 Applications June 29th 9:00am – 5:00pm (est.)
7. Adjournment

Meetings of the Grants Review Working Group will be held in a public session format except for the review of individual grant applications which will be conducted in closed session.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 
**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact  Dana Robson at the California Institute for Regenerative Medicine at 415-396-9132 no later than one day prior to the meeting.

Questions or requests for additional information prior to the Scientific & Medical Research Funding Working Group meeting may be referred to Dr. Gil Sambrano at the California Institute for Regenerative Medicine at gsambrano@cirm.ca.gov or 415-396-9103.

© 2013 California Institute for Regenerative Medicine